Related Experiment Videos
[Neurobrucellosis: clinical and therapeutic features]
P. Bellissima1, M.A. Turturici
1Divisione Malattie Infettive, Azienda Ospedaliera Gravina, Caltagirone, Catania, Italy.
Le Infezioni in Medicina
|May 7, 2003
Summary
Neurobrucellosis, a rare complication of brucellosis, can cause serious neurological issues. Early diagnosis and prompt treatment with antibiotics like rifampin and trimethoprim-sulfamethoxazole are crucial for favorable outcomes.
Area of Science:
- Infectious Diseases
- Neurology
- Zoonotic Diseases
Background:
- Brucellosis is a widespread zoonotic infection.
- Neurologic involvement (neurobrucellosis) is a rare but severe complication, affecting 2-5% of cases.
- Neurological symptoms can manifest during active disease or as delayed sequelae.
Purpose of the Study:
- To describe clinical presentations and diagnostic approaches for neurobrucellosis.
- To evaluate treatment outcomes for neurobrucellosis cases.
- To recommend a treatment regimen for neurobrucellosis.
Main Methods:
- Case series describing six patients with neurobrucellosis.
- Diagnostic methods included clinical history, exposure assessment, serum and cerebrospinal fluid (CSF) serology, CSF analysis, EEG, CT, and MRI.
- Treatment involved specific antibiotic regimens.
Main Results:
- The study detailed six cases of neurobrucellosis, including meningoencephalitis (2 cases), meningitis with brain abscess (1 case), and encephalomyelitis (3 cases).
- Diagnosis was confirmed by serological tests, CSF analysis, and neuroimaging.
- Patients showed a favorable response to antibiotic treatment.
Conclusions:
- Neurobrucellosis should be suspected in patients presenting with neurological deficits in endemic areas.
- A recommended treatment regimen includes intravenous rifampin and trimethoprim-sulfamethoxazole for 6-8 weeks.
- Prompt diagnosis and treatment are essential for managing this serious complication of brucellosis.